Overview

A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of repeat doses of solabegron and oxybutynin when taken alone or together
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Mandelic Acids
Oxybutynin
Solabegron